A fresh wave of high‑profile ALS diagnoses is putting a rare but devastating disease back in the spotlight, as actor, director and producer Russell Andrews has revealed he is living with the condition—just months after the death of Grey’s Anatomy star Eric Dane.
ALS, once widely known as Lou Gehrig’s disease, is a progressive neurological disorder that attacks nerve cells and strips away muscle control. Dane, remembered by millions as Dr. Mark “McSteamy” Sloan, died from the illness on February 19, adding to a growing list of well-known figures whose diagnoses have amplified public awareness.
The surge in celebrity cases can make ALS feel suddenly prevalent—but the reality is starkly different, neurologists have told Newsweek. A global study in Neuroepidemiology found only around 1.9 people per 100,000 develop the disease each year, underlining just how rare it remains. That disconnect between visibility and actual risk is why stories like this resonate: they humanize a condition most people will never encounter firsthand, while raising urgent questions about research, support and early detection.
Despite the cluster of cases in the public eye, neurologists stress there is no evidence linking ALS risk to careers in entertainment. Instead, experts told Newsweek the attention offers a rare chance to cut through misconceptions, spotlight the science, and refocus on the patients—famous or not—facing a disease that remains incurable.
Is There a Link Between ALS and the Entertainment Industry?
ALS progressively damages the nerve cells that control voluntary movement. As these motor neurons deteriorate and die, they can no longer activate the muscles they once powered, leading to increasing weakness and, eventually, paralysis.
A number of well‑known figures have spoken publicly about living with ALS—from astrophysicist Stephen Hawking to Killing Me Softly singer Roberta Flack and SpongeBob SquarePants creator Stephen Hillenburg, to name a few.
Dr. Rab Nawaz Khan, a board‑certified neurologist in the U.K., told Newsweek there is no known occupational connection.
“I am not aware of strong evidence showing that actors or people in the performing arts have a higher ALS risk as a profession,” he said.
Khan, who works as a stroke physician for MyMigraineTeam, added that a handful of public diagnoses can create the “visibility effect”—the illusion of a trend where none exists.
“A few public diagnoses can feel like a pattern even when the numbers may still be consistent with chance,” Khan said.
He emphasized that medicine relies on population‑level data, not anecdotal clusters, before identifying any true occupational risk.
What Actually Causes ALS?
The CDC estimates that roughly 35,000 people in the United States are currently living with the disease.
For most patients, the cause remains unknown.
Dr. Qiang Zhu, an ALS researcher at the Van Andel Institute in Michigan, told Newsweek that around 10 percent of diagnoses are hereditary. “Mutations in certain genes have been identified that can trigger ALS,” Zhu said.
“However, even among people with the same mutation, the age when symptoms begin and how severe the disease becomes can vary a lot. This strongly suggests that other factors also play a role.”
Researchers are now investigating how genes are switched on and off, along with other cellular and environmental influences that may contribute to the disease.
A number of well‑known figures from science, music, television, sports and theater have publicly shared their diagnoses. Here is a condensed list of notable individuals:
- Aaron Lazar—Broadway actor and singer
- Rebecca Luker — Broadway actress (died 2020)
- Eric Stevens—Former NFL fullback and firefighter
- John Driskell Hopkins — Co‑founder and bassist of the Zac Brown Band
- Jason Becker—Heavy metal guitarist and composer
Why High‑Profile Cases Feel Like a Trend
Khan told Newsweek that celebrity diagnoses can distort public perception: “High‑profile diagnoses create what I would call a visibility effect.”
When several actors, musicians or athletes announce the same disease, it can feel like a shared cause must exist—even when the data does not support that conclusion.
“Public awareness is valuable,” Khan said, “but it should lead to better education, research funding, and support for patients rather than speculation about unproven cause.”
Read the full article here
